Diabetes

Type 2 Diabetes Type 1 Diabetes Prediabetes Medications Diabetes Management Treatment Options Management Complications Treatment Blood Sugar Control

Eli Lilly to Invest $3 Billion in China to Build Orforglipron Manufacturing

The move targets localized production of the oral GLP-1 to strengthen supply ahead of potential approvals.

New Study Bolsters Case for Early Dinners, With a Three-Hour Pre-Bed Cutoff

GLP-1 Drugs Tied to Lower Addiction Risk and Harms in Large VA Study

GLP-1 Drugs Plus Healthy Habits Linked to Lower Heart Risk in Large VA Diabetes Study

Study Finds Waist-to-Height Ratio Outperforms BMI for Flagging Diabetes Risk in U.S. Youth

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Electronic Mesh Speeds Maturation of Lab-Grown Islet Cells in Peer-Reviewed Study

Eli Lilly Chooses Pennsylvania for $3.5 Billion Plant to Produce Weight-Loss Injectables

Lilly Signs Up to $1.12 Billion Gene-Editing Pact to Tackle Hearing Loss

Type 1 Diabetic Says 18-Hour Daily Fast Steadies Glucose as Experts Urge Caution

Peer-Reviewed Study Finds AI Eye Photo Test Can Screen for Diabetes

Daylesford Crash Driver Ordered to Testify at Inquest After Bid to Stay Silent Fails

Extreme Wedding Diet Leaves Hangzhou Woman Prediabetic, Doctors Say

Novo Nordisk Expands Aspect Partnership, Transfers Diabetes Cell Tech as Aspect Takes Lead

Lupin Strikes Semaglutide Licensing Deal With Galenicum Covering 23 Countries

Slime-Mold Enzyme Unlocks High-Yield Production of Low-Calorie Sugar Tagatose

Oxford Review Finds Rapid Weight Regain After Stopping GLP-1 Drugs

Breath-Based Glucose Pendant Debuts at CES as PreEvnt Seeks FDA Review

Daylight Exposure Improves Glucose Stability in Controlled Type 2 Diabetes Trial

Abbott Launches Libre Assist in FreeStyle Libre App to Predict Meal Glucose Impact